Variant report
Variant | rs3800312 |
---|---|
Chromosome Location | chr6:27210614-27210615 |
allele | A/C |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | TCF7L2 | chr6:27210454-27212017 | HEK293 | kidney: | n/a | n/a |
2 | CEBPB | chr6:27210588-27211061 | A549 | lung: | n/a | chr6:27210854-27210863 chr6:27210854-27210863 chr6:27210852-27210863 chr6:27210854-27210863 |
3 | POLR2A | chr6:27208304-27211412 | K562 | blood: | n/a | n/a |
4 | CTCF | chr6:27210540-27210690 | HFF-Myc | foreskin: | n/a | n/a |
5 | TEAD4 | chr6:27210320-27210734 | K562 | blood: | n/a | n/a |
6 | KAP1 | chr6:27210612-27211439 | U2OS | brain: | n/a | n/a |
7 | CTCF | chr6:27210540-27210690 | A549 | lung: | n/a | n/a |
8 | TEAD4 | chr6:27210330-27210997 | K562 | blood: | n/a | n/a |
9 | CTCF | chr6:27210540-27210690 | HCT-116 | colon: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:27208172..27214279-chr6:27217175..27221037,5 | MCF-7 | breast: | |
2 | chr6:27208791..27211821-chr6:27212133..27214069,3 | K562 | blood: | |
3 | chr6:27112441..27115377-chr6:27208801..27210793,2 | K562 | blood: | |
4 | chr6:27203954..27208601-chr6:27209090..27212437,6 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PRSS16 | TF binding region |
ENSG00000184825 | Chromatin interaction |
ENSG00000197903 | Chromatin interaction |
ENSG00000112812 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs11964003 | 1.00[CEU][hapmap];0.92[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs11964043 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs13437191 | 0.92[CHB][hapmap];1.00[JPT][hapmap];0.81[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs13437532 | 0.87[JPT][hapmap] |
rs17739298 | 0.86[CEU][hapmap] |
rs3800308 | 0.83[AFR][1000 genomes];0.82[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs3800311 | 0.93[CEU][hapmap];1.00[JPT][hapmap];0.88[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs3800313 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4145206 | 0.86[CEU][hapmap] |
rs4711143 | 0.87[JPT][hapmap] |
rs4711144 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4713074 | 0.87[GIH][hapmap] |
rs4713075 | 0.88[EUR][1000 genomes] |
rs4713077 | 0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs5030957 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs5030960 | 1.00[JPT][hapmap] |
rs58336089 | 0.98[AFR][1000 genomes];0.82[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs6902483 | 0.83[AFR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs6906761 | 0.92[CHB][hapmap];0.93[JPT][hapmap];0.80[ASN][1000 genomes] |
rs6912503 | 1.00[ASW][hapmap];1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];0.99[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs6918423 | 0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs6932243 | 0.92[CHB][hapmap];0.93[JPT][hapmap];0.80[ASN][1000 genomes] |
rs7755577 | 0.92[CHB][hapmap];0.87[CHD][hapmap];0.93[JPT][hapmap];0.80[ASN][1000 genomes] |
rs9393794 | 0.88[AFR][1000 genomes];0.82[AMR][1000 genomes];0.99[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs9461340 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.88[YRI][hapmap];0.86[AMR][1000 genomes];0.90[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs9468006 | 0.91[JPT][hapmap] |
rs9468011 | 0.85[AFR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs9468014 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs9468015 | 0.87[GIH][hapmap] |
rs9468016 | 1.00[CEU][hapmap];0.88[AFR][1000 genomes];0.82[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv948921 | chr6:26556890-27443957 | Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 472 gene(s) | inside rSNPs | diseases |
2 | nsv1017328 | chr6:27177147-27369588 | Bivalent Enhancer Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 29 gene(s) | inside rSNPs | diseases |
3 | nsv883505 | chr6:27210614-27300580 | Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Strong transcription Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 23 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:27207000-27212200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr6:27210400-27211000 | Enhancers | K562 | blood |
3 | chr6:27210600-27210800 | Bivalent Enhancer | HepG2 | liver |